Aerpio starts trial of drug for COVID blood vessel damageOne of the less well-known symptoms of COVID-19 is inflammation and injury to blood vessels, and US biotech Share XAerpio starts trial of drug for COVID blood vessel damagehttps://pharmaphorum.com/news/aerpio-starts-trial-of-drug-for-covid-blood-vessel-damage/
